SCHEMBL5344166

SCHEMBL5344166

O=C(Nc1ccc(C(=O)c2ccccc2)cc1)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 1.00
RAB9A P51151 4/20 1.00
MEN1 O00255 3/20 1.00
KMT2A Q03164 3/20 1.00
FFAR1 O14842 1/20 0.89
POLB P06746 3/20 0.78
KDM4E B2RXH2 2/20 0.78
PTPN1 P18031 3/20 0.75
CACNA1B Q00975 1/20 0.72
APBA1 Q02410 1/20 0.72
SIRT1 Q96EB6 1/20 0.71
MAPT P10636 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
ALDH1A1 P00352 1/20 0.69
L3MBTL1 Q9Y468 1/20 0.69
TDP1 Q9NUW8 2/20 0.66
CTDSP1 Q9GZU7 1/20 0.66
HPGD P15428 1/20 0.66
HDAC2 Q92769 1/20 0.66
HDAC8 Q9BY41 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8768933 1.00 NPC1 (1.00) NPC1RAB9AMEN1KMT2AFFAR1
SCHEMBL31432724 1.00 NPC1 (1.00) NPC1RAB9AMEN1KMT2AFFAR1
SCHEMBL8910428 0.96 NPC1 (0.92) NPC1RAB9AMEN1KMT2AFFAR1
SCHEMBL18103163 0.94 NPC1 (0.88) NPC1RAB9AMEN1KMT2AFFAR1
SCHEMBL14715824 0.94 NPC1 (0.88) NPC1RAB9AMEN1KMT2AFFAR1
SCHEMBL14484095 0.93 MEN1 (0.86) NPC1RAB9AMEN1KMT2AFFAR1
SCHEMBL26953087 0.91 PTPN1 (0.88) NPC1RAB9AMEN1KMT2AFFAR1
SCHEMBL126415 0.91 PTPN1 (0.87) NPC1RAB9AMEN1KMT2AFFAR1
SCHEMBL11936816 0.91 RAB9A (0.86) NPC1RAB9AMEN1KMT2AFFAR1
SCHEMBL14715847 0.89 PTPN1 (0.84) NPC1RAB9AMEN1KMT2AFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
EP-1675844-A1 PHENYL CARBOXAMIDE AND SULFONAMIDE DERIVATIVES FOR USE AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE Sterix Limited (GB) 2006-07-05 EP disclosed
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2005-10-13 US disclosed
WO-2005042513-A1 PHENYL CARBOXAMIDE AND SULFONAMIDE DERIVATIVES FOR USE AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE STERIX LIMITED (GB) 2005-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors HSD3B1, HSD3B2, HSD17B3 NPC1 1239/4885RAB9A 3856/4885MEN1 2978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.